Recombinant Mouse IL-28A/IFN-lambda 2 Protein
| Name | Recombinant Mouse IL-28A/IFN-lambda 2 Protein |
|---|---|
| Supplier | R&D Systems |
| Catalog | 4635-ML |
| Category | Protein |
| Prices | $319.00 |
| Sizes | 25 µg |
| Species Reactivities | Mouse |
| Nature | Recombinant |
| Source | Mouse myeloma cell line, NS0-derived Asp20-Val193, with a C-terminal 6-His tag |
| Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
| Bioactivity | Measured in an anti-viral assay using HepG2 human hepatocellular carcinoma cells infected with encephalomyocarditis (EMC) virus. Sheppard, P. et al . (2003) Nat. Immunol. 4 :63. The ED 50 for this effect is 0.75-3.75 ng/mL. |
| Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
| SwissProt/Accession | NP_001019844 |
| Gene | Ifnl2 |
| Sequence | Asp20 |
| Supplier Page | Shop |
Product images
When Recombinant Mouse Nectin-2/ CD112 (Catalog # 3869-N2) iscoated at 1 μg/mL, Recombinant Mouse DNAM-1/CD226 Fc Chimera (Catalog #4436-DN) binds with a typical ED 50 of 0.3-1.8 μg/mL.
Product References
Regulation of innate CD8+ T-cell activation mediated by cytokines. - Regulation of innate CD8+ T-cell activation mediated by cytokines.
Freeman BE, Hammarlund E, Raue HP, Slifka MK. Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9971-6. doi:
Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of - Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of
Kayamuro H, Yoshioka Y, Abe Y, Arita S, Katayama K, Nomura T, Yoshikawa T, Kubota-Koketsu R, Ikuta K, Okamoto S, Mori Y, Kunisawa J, Kiyono H, Itoh N, Nagano K, Kamada H, Tsutsumi Y, Tsunoda S. J Virol. 2010 Dec;84(24):12703-12.